General Information of the Compound
Compound ID
CP0114319
Compound Name
2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido)acetic acid
    Show/Hide
Synonyms
FG-2216
    Show/Hide
Structure
Formula
C12H9ClN2O4
Molecular Weight
280.667
Canonical SMILES
OC(=O)CNC(=O)c1nc(Cl)c2ccccc2c1O
    Show/Hide
InChI
InChI=1S/C12H9ClN2O4/c13-11-7-4-2-1-3-6(7)10(18)9(15-11)12(19)14-5-8(16)17/h1-4,18H,5H2,(H,14,19)(H,16,17)
    Show/Hide
InChIKey
OUQVKRKGTAUJQA-UHFFFAOYSA-N
Physicochemical Property
logP
1.4082
Rotatable Bonds
3
Heavy Atom Count
19
Polar Areas
99.52
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
4
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 6914666
SID: 14848734
ChEMBL ID
CHEMBL426560
DrugBank ID
DB08687
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02612, Egl nine homolog 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000273 Hep 3B2.1-7 Homo sapiens (Human)  1
1
IC50 = 3900 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 73 nM
2 IC50 = 300 nM
3 IC50 = 424.2 nM
4 IC50 = 640 nM
5 IC50 = 1400 nM
6 IC50 = 3900 nM
7 IC50 = 7500 nM
8 Kd < 1000 nM
Clinical Information about the Compound
Drug 1 ( FG-2216 )
Drug Name FG-2216
Indication
Kidney disease
Phase 2